Current evidence indicates that the anti-obesity effects of the classic KD are primarily mediated through two distinct pathways: GDF15-induced appetite suppression (reducing energy intake) and FGF21-enhanced energy expenditure (increasing metabolic activity) [16]. The gene discussed is GDF15; the disease is Obesity.